Spots Global Cancer Trial Database for Topical Rapamycin for Fibrofolliculomas
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Topical Rapamycin for Fibrofolliculomas
Official Title: Topical Rapamycin to Treat Fibrofolliculomas in Birt-Hogg-Dubé Syndrome
Study ID: NCT00928798
Conditions
Study Description
Brief Summary: The purpose of the study is to determine whether topical application of rapamycin can lead to reduction in size and/or number of fibrofolliculomas in BHD patients and may prevent the growth of new ones. Secondary we evaluate rapamycin safety, formula acceptance and patient satisfaction.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
VU Medical Centre Amsterdam, Amsterdam, , Netherlands
Maastricht University Medical Centre, Maastricht, , Netherlands
Contact Details
Name: Maurice van Steensel, Dr.
Affiliation: Department of Dermatology
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
